Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers (NCT03163680) | Clinical Trial Compass
CompletedNot Applicable
Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
Syria295 participantsStarted 2012-01
Plain-language summary
Determining the efficacy of low dose of PPI in management acute peptic ulcer bleeding
Who can participate
Age range18 Years – 90 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Criteria:
Inclusion Criteria:
High risk ulcers defined according to the Forrest classification With respect to high-risk stigmata, active bleeding was defined as a continuous blood spurting (Forrest IA) oozing (Forrest IB) from the ulcer base. A non-bleeding visible vessel at endoscopy was defined as a discrete protuberance at the ulcer base(Forrest IIA).
An adherent clot was one that was resistant to forceful irrigation or suction (Forrest IIB).
Exclusion Criteria:
ulcer was malignant non ulcerative bleeding such as angiodysplasia , a Mallory-Weiss tear